Alkermes plc - Ordinary Shares (ALKS) earnings
ALKS earnings moved a median of +0.36% by the close. Quarterly and annual ALKS reports and results, each read against the price at its own news timestamp. Back to the ALKS overview →
21 measured ALKS earnings events.
Where these ALKS earnings landedvs 19 measured ALKS earnings reactions
| Middle 50% of ALKS earnings reactions | -0.78% to +2.48% |
|---|---|
| Median reaction (to close) | +0.36% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ALKS earnings events with a measured close landed between -0.78% and +2.48%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Alkermes plc Reports Second Quarter 2026 Financial Results | Press release | +3.06% | +0.36% | |
| Form 10-Q Alkermes plc. For: Jun 30 | SEC filing · Form 10-Q | +3.06% | +0.36% | |
| Alkermes plc Reports First Quarter 2026 Financial Results | Press release | -1.60% | +2.84% | |
| Form 10-Q Alkermes plc. For: Mar 31 | SEC filing · Form 10-Q | +0.45% | -2.73% | |
| Form 10-K Alkermes plc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.23% | |
| Alkermes plc Reports Third Quarter 2025 Financial Results | Press release | -3.87% | +2.48% | |
| Form 10-Q Alkermes plc. For: Sep 30 | SEC filing · Form 10-Q | -3.87% | +2.48% | |
| Alkermes plc Reports Second Quarter 2025 Financial Results | Press release | -3.13% | — | |
| Form 10-Q Alkermes plc. For: Jun 30 | SEC filing · Form 10-Q | -3.13% | — | |
| Alkermes plc Reports First Quarter 2025 Financial Results | Press release | +0.31% | +6.44% | |
| Form 10-Q Alkermes plc. For: Mar 31 | SEC filing · Form 10-Q | +0.02% | +2.45% | |
| Form 10-K Alkermes plc. For: Dec 31 | SEC filing · Form 10-K | +0.22% | +7.50% | |
| Alkermes plc Reports Third Quarter 2024 Financial Results | Press release | +0.41% | -0.78% | |
| Form 10-Q Alkermes plc. For: Sep 30 | SEC filing · Form 10-Q | +0.41% | -0.78% | |
| Alkermes plc Reports Second Quarter 2024 Financial Results | Press release | -3.01% | -1.45% | |
| Form 10-Q Alkermes plc. For: Jun 30 | SEC filing · Form 10-Q | -3.01% | -1.45% | |
| Alkermes plc Reports First Quarter 2024 Financial Results | Press release | +0.71% | +0.67% | |
| Form 10-Q Alkermes plc. For: Mar 31 | SEC filing · Form 10-Q | -1.05% | -0.04% | |
| Form 10-K Alkermes plc. For: Dec 31 | SEC filing · Form 10-K | +0.71% | -0.38% | |
| Alkermes plc Reports Third Quarter 2023 Financial Results | Press release | +0.00% | -0.51% | |
| Form 10-Q Alkermes plc. For: Sep 30 | SEC filing · Form 10-Q | +1.59% | +3.52% |
Keep exploring
More ALKS: analyst actions → · SEC filings → · ALKS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | 482 | 0.00% | 50% |
| Medtronic plc. Ordinary Shares (MDT) | 481 | -0.06% | 45% |
| HCA Healthcare, Inc. (HCA) | 479 | +0.30% | 62% |
| NEOS THERAPEUTICS (NEOS) | 479 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.